|Bid||4.60 x 1000|
|Ask||5.50 x 1100|
|Day's Range||4.6600 - 4.8000|
|52 Week Range||3.1300 - 5.6500|
|Beta (3Y Monthly)||2.15|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 8, 2017 - Nov 13, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||6.00|
NEW YORK, Feb. 13, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
SOMERSET, N.J, Feb. 07, 2019 -- MTBC (NASDAQ:MTBC) (NASDAQ: MTBCP), a leading provider of cloud-based healthcare IT solutions and services, today announced the official change.
MTBC (MTBC) (MTBCP), a leading provider of proprietary, cloud-based healthcare IT solutions and services, today announced that it will present at the 2019 HIMSS Global Conference & Exhibition on February 14, 2019, in Orlando, Florida. The Company will present its Blockchain Electronic Health Records (EHR) Network platform at the Orange County Convention Center’s Innovation Live Pavilion at 3:15-3:35 pm Eastern Time. MTBC’s presentation will focus on its permission-based blockchain network, which creates the capability to exchange medical records between multiple EHR systems.
SOMERSET, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) -- MTBC (MTBC) (MTBCP), a leading provider of proprietary, cloud-based healthcare IT solutions and services, today provided preliminary results for its record-breaking year ended December 31, 2018 and preliminary expectations for revenue and adjusted EBITDA growth in 2019. “MTBC completed a transformational year in 2018 as we significantly expanded our healthcare technology and service offering, more than doubled the number of healthcare providers leveraging our solutions and welcomed additional talented team members to support our continued growth,” said Stephen Snyder, Chief Executive Officer.
We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be remiss not to mention that insider sales have Read More...
Accumulation is close to an all-time high, signaling strong speculative interest. A cup and handle breakout would yield an impressive measured move target near $9.50, which is close to a 2015 breakdown into single digits.
Medical Transcription Billing Corp (MTBC) reported financial results for their third quarter 2018 and provided a business update. Financial performance is already benefitting from the transaction with Q3 setting new record highs in revenue, revenue growth and consecutive quarters (i.e.
Penny stocks got battered and bruised during the month of October, undermined by a broad-based retreat that dropped the Russell 2000 small-cap index to an eight-month low. The broad market could post new lows in early November, but a profitable relief rally should unfold in coming weeks, favoring dip trades on penny stocks that have held technical support levels through the maelstrom. This month's penny stock list includes several of these plays, but it's important to think and act defensively, placing stop losses immediately after entry. Penny Stock Picks to Buy Using Technical Analysis for November 1.
If you’re interested in Medical Transcription Billing Corp (NASDAQ:MTBC), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock Read More...
The Digital Issue of the Fall 2018 MicroCap Review Magazine, The Official Magazine for the MicroCap Stock Market, can be read on www.StockNewsNow.com LOS ANGELES, CA / ACCESSWIRE / October 9, 2018 / SNN ...
Blue chips led broad price action in September, lifting the S&P 500 and the Dow Jones Industrial Average to bull market highs while small cap indices such as the Russell 2000 pulled back in shallow declines. Penny and low-priced stocks held up well during the month despite this headwind, with traders scooping up junior energy plays in reaction to a surging crude oil market. Penny stock buyers have taken notice, lifting the shares of low-priced American oil and gas companies still reeling from the group's historic decline into 2016.